AusPAR: Nuvaxovid heterologous booster

AusPAR

AusPAR Product Information: NUVAXOVID heterologous booster [PDF, 562.27 KB]

AusPAR Product Information: NUVAXOVID heterologous booster [Word, 77.92 KB]

AusPAR: NUVAXOVID heterologous booster [PDF, 1.93 MB]

AusPAR: NUVAXOVID heterologous booster [Word, 7.97 MB]

Device/Product Name

Nuvaxovid heterologous booster

Active ingredients

SARS-CoV-2 rS vaccine with Matrix-M1 adjuvant

AusPAR Date

22 June 2022

Published

24 June 2022

Submission Number

PM-2022-00638-1-2

Submission Type

Major variation (change in dose regimen)

Decision

Approved for provisional registration